Insider Monkey • 2 hours ago
Like everyone else, successful investors make mistakes. Some of their top consensus picks, such as Valeant and SunEdison, have not done well during the last 12 months due to various reasons. Nevertheless, the data show successful investors’ consensus picks have done well on average. The top 30 mid-cap stocks (market caps between $1 billion and […]
24/7 Wall St. • 2 days ago
December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by about 3 to 2 and on ...
Barrons.com • 3 days ago
BMO's M. Ian Somaiya and team contend that while Gilead Sciences' (GILD) hepatitis-c sales will remain under pressure, its HIV business should make up for it: We sat down with Gilead management during ...
Forbes • 3 days ago
If a company is not going to get very good pricing for excellent new drugs, then the biopharmaceutical industry will likely stagnate and many new opportunities for drug R&D will not be able to be funded.
Motley Fool • 5 days ago
Bristol-Myers Squibb and Gilead Sciences are strong buys after a poor 2016. But Dynavax is probably best avoided after its steep drop-off this year.
Bloomberg Video • yesterday
Dec.09 -- Rupal Bhansali, chief investment officer of global equities at Ariel Investments, discusses navigating uncertainty after the U.S. election and health care stocks. She speaks with David Gura on "Bloomberg Markets."
CNBC Videos • 2 days ago
Chris Retzler, Needham Growth Fund, and Ronny Gal, Sanford C. Bernstein, discuss buying opportunities amid health care's underperformance. With CNBC's Mike Santoli and Stephanie Link, TIAA Global Asset Management.
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||72.64 x 500|
|Ask||72.80 x 200|
|Day's Range||71.95 - 73.13|
|52 Week Range||70.83 - 104.79|
|PE Ratio (TTM)||6.72|
|Earnings Date||Jan 31, 2017 - Feb 6, 2017|
|Dividend & Yield||1.88 (2.59%)|
|1y Target Est||95.92|